Share chart Embecta Corp.
Extended chart
Simple chart
Main settings
Currency
usd
Dividend income of JSC
4.21
Dividend of JSC
0.3
IPO Time
2022-04-01
ISIN
US29082K1051
Industry
Health Care Equipment & Supplies
Report Currency
usd
Sector
Health Care
Website
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0.7323 | 10 |
| P/BV | -1.11 | 0 |
| P/E | 10.5 | 9 |
Efficiency
| Title | Value | Grade |
| ROA | 6.26 | 2 |
| ROE | -10.04 | 0 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 4.27 | 10 |
| DSI | 1 | 10 |
| Average dividend growth | 30.56 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 8.08 | 0 |
| Debt/Ratio | 1.25 | 8 |
| Debt/Equity | -2.74 | 10 |
Growth impulse
| Title | Value | Grade |
| Revenue, bln, % | 3.42 | 1 |
| Ebitda, % | -62.1 | 0 |
| EPS, % | -82.12 | 0 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 13.9 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 14.34 $ | 0 $ | 0 $ | -3.07 % | 0 % | 0 % |
| Month | 14.5 $ | 13.69 $ | 15.31 $ | -4.14 % | 0 % | 0 % |
| Three month | 9.64 $ | 9.58 $ | 15.31 $ | +44.19 % | 0 % | 0 % |
| Half a year | 12.75 $ | 9.28 $ | 15.31 $ | +9.02 % | 0 % | 0 % |
| Year | 16.42 $ | 9.28 $ | 20.93 $ | -15.35 % | 0 % | 0 % |
| 3 years | 9.28 $ | 9.28 $ | 35.48 $ | +149.78 % | 0 % | 0 % |
| 5 years | 9.28 $ | 9.28 $ | 55.5 $ | +149.78 % | 0 % | 0 % |
| 10 years | 9.28 $ | 9.28 $ | 55.5 $ | +149.78 % | 0 % | 0 % |
| Year to date | 20.23 $ | 9.28 $ | 20.93 $ | -31.29 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Syntax Stratified SmallCap ETF | 0.93966 | -41.87 | 0.40 |
| iShares Morningstar Small-Cap Value ETF | 0.03863 | 173.73 | 0.06 |
| iShares Morningstar Small-Cap ETF | 0.01902 | 293.87 | 0.25 |
| 0.33 | 141.91 | 0.24 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Devdatt Kurdikar | President, CEO & Director | 2.2M | 1969 (56 years) |
| Mr. Jacob P. Elguicze | Senior VP & CFO | 1.05M | 1973 (52 years) |
| Mr. Jeffrey Z. Mann | Senior VP, General Counsel, Head of Business Development & Corporate Secretary | 959.45k | 1972 (53 years) |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 915.67k | 1969 (56 years) |
| Mr. Brian R. Capone | VP, Chief Accounting Officer & Corporate Controller | 645.16k | 1975 (50 years) |
| Ms. Colleen Riley | Senior VP & Chief Technology Officer | N/A | 1964 (61 year) |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management | N/A | |
| Mr. Tom Blount | Senior VP & President of North America | N/A | 1974 (51 year) |
| Mr. Pravesh Khandelwal | VP & Head of Investor Relations | N/A | |
| Ms. Jean M. Casner | Senior VP & Chief Human Resources Officer | N/A | 1958 (67 years) |
About company
Address: United States, Parsippany. NJ, 300 Kimball Drive - Open in google maps, Open in yandex maps
Website: https://www.embecta.com
Website: https://www.embecta.com
About Embecta Corp.
Embecta Corp., компания по производству медицинского оборудования, специализируется на предоставлении различных решений для улучшения здоровья и благополучия людей, живущих с диабетом. Его продукция включает иглы для авторучек, шприцы и устройства безопасности, а также цифровые приложения, помогающие людям справляться с диабетом. Компания в основном продает свою продукцию оптовикам и дистрибьюторам в США и за рубежом. Embecta Corp. была основана в 1924 году и базируется в Парсиппани, штат Нью-Джерси. Embecta Corp. (Nasdaq:EMBC) работает независимо от Becton, Dickinson and Company с 1 апреля 2022 года.
